Bio Essence Corporation
BIOE
$0.23
$0.0188.49%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 22.20K | 147.60K | 134.70K | 41.70K | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 22.20K | 147.60K | 134.70K | 41.70K | -- |
| Cost of Revenue | 1.60K | 40.70K | 53.70K | 12.50K | -- |
| Gross Profit | 20.60K | 106.90K | 81.00K | 29.20K | -- |
| SG&A Expenses | 225.70K | 103.00K | 227.40K | 194.20K | 151.80K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | 49.30K | -- |
| Total Operating Expenses | 227.30K | 143.70K | 281.10K | 256.00K | 151.80K |
| Operating Income | -205.10K | 3.90K | -146.40K | -214.30K | -151.80K |
| Income Before Tax | -205.80K | -27.60K | -1.20M | -214.90K | -123.00K |
| Income Tax Expenses | -- | 0.00 | -- | 800.00 | -- |
| Earnings from Continuing Operations | -205.80K | -27.60K | -1.20M | -215.70K | -123.00K |
| Earnings from Discontinued Operations | -- | 0.00 | -- | -- | 256.90K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -205.80K | -27.60K | -1.20M | -215.70K | 133.90K |
| EBIT | -205.10K | 3.90K | -146.40K | -214.30K | -151.80K |
| EBITDA | -205.00K | 4.10K | -146.40K | -214.00K | -151.30K |
| EPS Basic | -0.01 | 0.00 | -0.03 | -0.01 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | -0.01 | 0.00 | -0.03 | -0.01 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 38.01M | 38.01M | 38.01M | 38.01M | 38.01M |
| Average Diluted Shares Outstanding | 38.01M | 38.01M | 38.01M | 38.01M | 38.01M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |